<SEC-DOCUMENT>0001193805-24-001551.txt : 20241231
<SEC-HEADER>0001193805-24-001551.hdr.sgml : 20241231
<ACCEPTANCE-DATETIME>20241231141703
ACCESSION NUMBER:		0001193805-24-001551
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20241231
DATE AS OF CHANGE:		20241231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SEALSQ Corp
		CENTRAL INDEX KEY:			0001951222
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278685
		FILM NUMBER:		241592430

	BUSINESS ADDRESS:	
		STREET 1:		AVENUE LOUIS-CASAI 58
		CITY:			COINTRIN
		STATE:			V8
		ZIP:			1216
		BUSINESS PHONE:		212-336-2039

	MAIL ADDRESS:	
		STREET 1:		CRAIGMUIR CHAMBERS, ROAD TOWN
		CITY:			TORTOLA
		STATE:			D8
		ZIP:			VG 1110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SEAL (BVI) Corp.
		DATE OF NAME CHANGE:	20221019
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>e664117_424b3-sealsq.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>

</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="margin: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Filed Pursuant to Rule
424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Registration&nbsp;No.&nbsp;333-278685</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>PROSPECTUS SUPPLEMENT NO. 6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>(TO PROSPECTUS DATED SEPTEMBER 24, 2024)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 51.75pt; width: 158.25pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This prospectus
supplement updates and supplements the prospectus dated September <FONT STYLE="font-family: Times New Roman, Times, Serif">24</FONT>,
2024 (the &ldquo;Prospectus&rdquo;), which forms a part of our registration statement on Form F-1 (No. 333-278685). This prospectus supplement
is being filed to update and supplement the information in the Prospectus with information contained in our Current Report on Form 6-K
filed with the Securities and Exchange Commission on <FONT STYLE="font-family: Times New Roman, Times, Serif">December 30</FONT>, 2024
(the &ldquo;Current Report&rdquo;). Accordingly, we have attached the Current Report to this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #231F20">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This Prospectus
and prospectus supplement relate</FONT> to the resale, from time to time, by the selling shareholders named in the Prospectus (the &ldquo;Selling
Shareholders&rdquo;) of an aggregate of up to 40,000,000 of our Ordinary Shares, US$0.01 par value per Ordinary Share (the &ldquo;Ordinary
Shares&rdquo;), reserved for issuance (i) upon the conversion of currently outstanding 2.5% discount convertible promissory notes (the
&ldquo;Notes&rdquo;) held by the Selling Shareholders (the &ldquo;Conversion Shares&rdquo;), (ii) upon exercise of currently outstanding
warrants (the &ldquo;Third Tranche Warrants&rdquo;) held by the Selling Shareholders (the &ldquo;Third Tranche Warrant Shares&rdquo;),
and (iii) the outstanding warrants that were issued on January 9, 2024 (the &ldquo;Second Tranche Warrants&rdquo;, and together with the
Third Tranche Warrants, the &ldquo;Warrants&rdquo;) and held by the Selling Shareholders (the &ldquo;Second Tranche Warrant Shares&rdquo;,
and together with the Third Tranche Warrant Shares, the &ldquo;Warrant Shares&rdquo;). The Notes and Third Tranche Warrants were issued
to the Selling Shareholders on March 1, 2024 (the &ldquo;Closing Date&rdquo;).&nbsp;All of the Notes have been previously converted by the Selling Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We registered the resale of up to an aggregate
of 40,000,000 Conversion Shares and Warrant Shares as required by the Registration Rights Agreement, dated as of July 11, 2023, as amended
(the &ldquo;Registration Rights Agreement&rdquo;), by and among us and the Selling Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">1</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that Conversion Shares and/or Warrant
Shares are issued by the Company under the terms of the Notes and Warrants, substantial amounts of Ordinary Shares could be issued and
resold, which would cause dilution and may impact the Company&rsquo;s share price. See &ldquo;Risk Factors&rdquo; and &ldquo;Convertible
Note Financing&rdquo; for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not selling any securities under this prospectus
and will not receive any of the proceeds from the sale of our Conversion Shares or Warrant Shares by the Selling Shareholders. However,
we may receive proceeds from the exercise of the (i) Second Tranche Warrants, which, if exercised in full for an aggregate of 3,033,159
Ordinary Shares and for cash at the current $1.65 exercise price per Ordinary Share&nbsp;(as repriced on December 30, 2024), would result in gross proceeds to us of approximately
$5,004,712 and (ii)Third Tranche Warrants, which, if exercised in full for an aggregate of 2,821,498 Ordinary Shares and for cash at the
current $1.65 exercise price per Ordinary Share&nbsp;(as repriced on December 30, 2024), would result in gross proceeds to us of approximately $4,655,471. There is no assurance
that the Selling Shareholders will elect to exercise all of the outstanding Warrants for cash and, accordingly, no assurance that we will receive
the full proceeds from the exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will pay the expenses of registering the Conversion
Shares and Warrant Shares offered by this prospectus, but all selling and other expenses incurred by the Selling Shareholders will be
paid by the Selling Shareholders. The Selling Shareholders may sell the Conversion Shares and the Warrant Shares offered by this prospectus
from time to time on terms to be determined at the time of sale through ordinary brokerage transactions or through any other means described
in this prospectus under &ldquo;Plan of Distribution.&rdquo; The prices at which the Selling Shareholders may sell the Conversion Shares
or the Warrant Shares will be determined by the prevailing market price for our Ordinary Shares or in negotiated transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Our Ordinary
Shares are listed on the Nasdaq Capital Market under the ticker symbol &ldquo;LAES.&rdquo; The last reported sale price of our Ordinary
Shares on the Nasdaq Capital Market on December 30, 2024 was $8.57 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus supplement should be read in conjunction
with, and delivered with, the Prospectus and is qualified by reference to the Prospectus except to the extent that the information in
this prospectus supplement supersedes the information contained in the Prospectus. This prospectus supplement is not complete without,
and may not be delivered or utilized except in connection with, the Prospectus, including any amendments or supplements to it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our Ordinary Shares involves risks.
See &ldquo;Risk Factors&rdquo; beginning on page 18 of the Prospectus for a discussion of information that should be considered in connection
with an investment in our Ordinary Shares.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the U.S. Securities and Exchange Commission
(&ldquo;SEC&rdquo;) nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy
of this Prospectus Supplement No. 6. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">The date of this Prospectus
Supplement is <FONT STYLE="font-family: Times New Roman, Times, Serif">December 31</FONT>, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">2</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 153.2pt 0pt 153.05pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 153.2pt 0pt 153.05pt; text-align: center"><B>SECURITIES AND EXCHANGE
COMMISSION WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>FORM 6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Report of Foreign Private
Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Pursuant to Rule 13a-16 or 15d-16 under the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Securities Exchange Act
of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of December 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Commission File
Number: 001-41709</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-size: 18pt"><B>SEALSQ
CORP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Exact Name of
Registrant as Specified in Charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>N/A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Translation
of Registrant&rsquo;s name into English)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>British Virgin Islands</B></FONT></TD>
    <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Avenue
                           Louis-Casa&iuml; 58</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>1216 Cointrin,
Switzerland </B></FONT>&nbsp;</P></TD>
    <TD STYLE="width: 33%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Not Applicable</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive office)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&#9746; Form
20-F&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#9744; Form 40-F</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<HR SIZE="2" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: black">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Warrant Inducement Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 30, 2024, SEALSQ
Corp (the &ldquo;Company&rdquo;) entered into a letter agreement (the &ldquo;Warrant Inducement Agreement&rdquo;) with the holders (the
&ldquo;Investors&rdquo;) of all of its outstanding warrants in order to provide the Investors with an opportunity to exercise such warrants
to purchase ordinary shares, par value $0.01 per share of the Company (the &ldquo;Ordinary Shares&rdquo;), at a reduced exercise price
and to receive additional Ordinary Shares upon exercise of such warrants, in each case prior to the Exercise Date (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Warrant Inducement
Agreement, the Company agreed to reduce the exercise price per Ordinary Share issuable upon exercise of a Warrant (&ldquo;Warrant Share(s)&rdquo;)
for (i) the July 2023 warrants (the &ldquo;First Tranche Warrants&rdquo;) to purchase Warrant Shares, (ii) the January 2024 warrants (the
&ldquo;Second Tranche Warrants&rdquo;) to purchase Warrant Shares and (iii) the January 2024 warrants (the &ldquo;Third Tranche Warrants&rdquo;
and collectively with the First Tranche Warrants and the Second Tranche Warrants, the &ldquo;Warrants&rdquo;) to purchase Warrant Shares,
in each case from $2.00 to $1.65 per Warrant Share payable in cash provided that the Investors exercise the Warrants on or prior to 5:00
p.m. (New York Time) January 3, 2025 (the &ldquo;Exercise Date&rdquo;). In addition, in the event that the Warrants are exercised by the
Exercise Date, the number of Warrant Shares issuable upon the exercise of the Warrants shall be increased such that the aggregate exercise
price payable upon the exercise of such Warrants after taking into account the decrease in exercise price of such Warrants shall be equal
to the aggregate exercise price of such Warrants prior to such adjustment.&nbsp;As a result, if the First Tranche Warrants are exercised by the Exercise Date, the number of Warrant Shares issuable will be 4,469,382;
if the Second Tranche Warrants are exercised by the Exercise Date, the number of Warrant Shares issuable will be 3,033,159; if the Third
Tranche Warrants are exercised by the Exercise Date, the number of Warrant Shares issuable will be 2,821,498.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the purchase
of the Warrant Shares underlying the First Tranche Warrants, if no effective registration statement and current prospectus is available
on or prior to 9:00 a.m. (New York Time) on January 3, 2025, the exercise price of the Warrant Shares underlying the First Tranche Warrants
shall be further reduced to $1.30 per Warrant Share and the number of Warrant Shares issuable upon the exercise of the First Tranche Warrants
shall be further increased such that the aggregate exercise price payable upon the exercise of such First Tranche Warrants after taking
into account the additional decrease in exercise price of such First Tranche Warrants shall be equal to the aggregate exercise price of
such First Tranche Warrants prior to such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Under
the Warrant Inducement Agreement, the Company and the Investors agreed to waive the obligations of the Company and the Investors as set
forth in (i) Section 4.19 of the Securities Purchase Agreement, dated as of December 12, 2024, by and among the Company and the Investors,
to close an additional convertible note tranche in an aggregate principal amount of $10.0 million pursuant to that certain securities
purchase agreement, dated July 11, 2023, as amended, by January 16, 2025, and (ii) Section 4.15 in each of the Securities Purchase Agreements,
dated as of December 12, 2024, December 16, 2024 and December 17, 2024, by and among the Company and the Investors. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offering of Ordinary Shares
to be issued to the Investors upon exercise of the First Tranche Warrants was made pursuant to the Company&rsquo;s existing shelf registration
statement on Form F-3 (File No. 333-283358), which was declared effective on November 27, 2024 by the U.S. Securities and Exchange Commission
(the &ldquo;Registration Statement&rdquo;). A prospectus supplement to the Registration Statement is expected to be filed with the Commission
on or around January 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Ordinary Shares issuable
upon exercise of the Second Tranche Warrants and the Third Tranche Warrants were registered for resale under the Company&rsquo;s registration
statement on Form F-1/A (File No. 333-278685) filed on September 12, 2024 and declared effective on September 24, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Warrant Inducement Agreement is qualified in its entirety by reference to the full text of the Warrant Inducement Agreement, which
is attached to this Report of Foreign Private Issuer on Form 6-K as Exhibit 10.1 and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing information
contained in this Report on Form 6-K (this &ldquo;Report&rdquo;) and Exhibit 10.1 filed herewith is hereby incorporated by reference in
the Company&rsquo;s Registration Statement on Form F-3 (File No. 333- 283358) and is deemed to be a part thereof from the date on which
this Report is filed, to the extent not superseded by documents or reports subsequently filed with or furnished to the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15pt 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-weight: normal">This
Report shall not constitute an offer to sell or a solicitation of an offer to buy any Ordinary Shares, nor shall there be any sale of
Ordinary Shares in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state or other jurisdiction.<BR STYLE="clear: both">
</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 153.2pt 0pt 153.05pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 153.2pt 0pt 153.05pt; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 153.2pt 0pt 153.05pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 153.2pt 0pt 153.05pt; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.45pt"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Date: December 30, 2024</TD>
    <TD COLSPAN="2"><B>SEALSQ CORP</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By: </TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Carlos Moreira</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Carlos Moreira</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ John O&rsquo;Hara</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>John O&rsquo;Hara</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.45pt"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 415.65pt; text-align: right; text-indent: 2.9pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 15%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>No.</U></P>

</TD>
  <TD><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
      <P STYLE="margin-top: 0; margin-bottom: 0"><U>Description</U></P></TD>
  <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center">10.1</TD>
  <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1951222/000119380524001545/e664116_ex10-1.htm">Form of Warrant Inducement Letter Agreement</A></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center">99.1</TD>
  <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1951222/000119380524001545/e664116_ex99-1.htm">Press Release, dated December 30, 2024</A></TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 415.65pt; text-align: right; text-indent: 2.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 415.65pt; text-align: right; text-indent: 2.9pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% -,# 2(  A$! Q$!_\0
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M-U'&:U2."^(?Q(U71/$-OX<\/623ZA($+.ZER2V<(JCOT.3Z]*PO^$D^,?\
MT!?_ "57_&NA^(OP[U+6]9M?$7ARZ$&JP!596;;NV_=96[$=/?CICGGO[-^-
M?_/[_P"1;?\ PKQ#T3K_  /JOC:\CU5_%5E]F6&)6MCY03<WS9Z'GH*X/0_'
MOQ0\202SZ1:VUU'$VQRL2#:<9[L*Z/X?^-==U*_UOPSXFVOJ-G#(ZR;54_*=
MK*=ORGJ""/?KQ7!> ;/QE=^'[@>$+CR66Z/VD[T7(V+M^]_P*@#KO[9^,_\
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MS6]6U=9U?>D3N8SLCD=0RQLW0,01^8]1FO\ \)7IPMK>XV76VX9A$/).YU4
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MM^B@#,&AVRWBW0>;>MZ;T#(QO,)AQTZ;23ZY[]JTZ** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
